@FiercePharma: Novartis CEO goes on a 'decluttering' drive. Report | Follow @FiercePharma
> Merck has agreed to let Glenmark Pharmaceuticals sell a generic version of the cholesterol medicine Zetia in the U.S. by December 2016 as part of a settlement of a patent-infringement lawsuit. Release | Report
> India's Ranbaxy Laboratories raced past estimates with its fourth straight quarterly profit and kept ambitious earnings forecasts unchanged for the year. Report
> Drug shortages in the U.K. could remain into next year as parallel traders continue to cash in on the weak pound, according to British Association of European Pharmaceutical Distributors. Report
> Salix Pharmaceuticals' first-quarter loss widened less than it had expected, and the drugmaker also projected a second-quarter profit, which would be its first time in the black in more than two years. Report
> Indian outsourcing provider HCL Technologies has announced a $500 million, five-year deal with Merck, through which HCL will providing BPO, KPO and engineering services. Report
> Purdue Pharma has filed a patent infringement suit against India's Ranbaxy, after the latter applied for marketing approval of a low-cost version of Purdue's pain medicine Oxycodone. Report
Biotech News
@FierceBiotech: Frenchay Hospital trials offer MS stem cell hopes. Article | Follow @FierceBiotech
@JohnCFierce: Tiny Avexa has buried its HIV therapy, demolishing its share price and leaving it scrambling for a survival strategy. Article | Follow @JohnCFierce
> NicOx shares dive after regulators question naproxcinod's benefits. Report
> 'New Merck' spotlights late-stage strategy but shelves biosimilar. Item
> Roche adds $201M in milestones to Galapagos R&D pact. Story
> Test maker's shares soar on GSK cancer pact. Article
> Mayo team discovers new diabetes drug class. News
Manufacturing News
> "Concerned" J&J hopes to stop monthly Tylenol recalls. Story
> Drugmakers: Trypsin likely culprit in Rotavirus vax contamination. News
> Teva, Baxter fined $500M for propofol-vial reuse infections. Report
> Chinese heparin maker's stock falls after strong debut. News
> Findings could aid vax distribution in developing nations. Item
Biotech Research News
> Mayo investigators discover a new class of diabetes drugs. Report
> Aging expert heralds new class of therapeutics. Article
> Senate panel mulls NIH drug development plan. News
> Researchers measure pain in the expressions of lab mice. Story
And Finally... In the race to find answers about ovarian cancer, researchers now have something to cluck about. Report